Zynerba Pharmaceuticals Inc logo

Zynerba Pharmaceuticals Inc

$ 0.76 -0.0161 (-2.07%) 10:08 PM EST
P/E:
At Loss
P/B:
0.59
Market Cap:
$ 34.77M
Enterprise V:
$ -26.53M
Volume:
442.29K
Avg Vol (2M):
467.39K
Also Trade In:
Volume:
442.29K
Market Cap $:
34.77M
PE Ratio:
At Loss
Avg Vol (2-Month):
467.39K
Enterprise Value $:
-26.53M
PB Ratio:
0.59
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.
Name Current Vs Industry Vs History
Cash-To-Debt 139.18
Equity-to-Asset 0.85
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 28.01
9-Day RSI 26.05
14-Day RSI 27.87
6-1 Month Momentum % -45.63
12-1 Month Momentum % -73.21

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.89
Quick Ratio 6.89
Cash Ratio 6.56

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -32.7
Name Current Vs Industry Vs History
ROE % -52.46
ROA % -45.94
ROIC % -860.18
ROC (Joel Greenblatt) % -3810.31
ROCE % -51.35

Financials (Next Earnings Date:2022-11-15 Est.)

ZYNE's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ZYNE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.93
Beta 0.99
Volatility % 55.19
14-Day RSI 27.87
14-Day ATR ($) 0.09177
20-Day SMA ($) 0.97346
12-1 Month Momentum % -73.21
52-Week Range ($) 0.7099 - 4.355
Shares Outstanding (Mil) 45.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Zynerba Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Zynerba Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.